These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11567210)

  • 21. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
    Souto EB; Müller RH
    Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
    Mandawgade SD; Patravale VB
    Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations on 5-fluorouracil solid lipid nanoparticles (SLN) prepared by hot homogenization.
    Mao S; Wang P; Bi D
    Pharmazie; 2005 Apr; 60(4):273-7. PubMed ID: 15881607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
    Müller RH; Runge SA; Ravelli V; Thünemann AF; Mehnert W; Souto EB
    Eur J Pharm Biopharm; 2008 Mar; 68(3):535-44. PubMed ID: 17804210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of the crystallinity of lipid nanoparticles on their occlusive properties.
    Wissing S; Müller R
    Int J Pharm; 2002 Aug; 242(1-2):377-9. PubMed ID: 12176283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB; Müller RH
    Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
    Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
    Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
    Kalariya M; Padhi BK; Chougule M; Misra A
    Indian J Exp Biol; 2005 Mar; 43(3):233-40. PubMed ID: 15816409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Employment of cationic solid-lipid nanoparticles as RNA carriers.
    Montana G; Bondì ML; Carrotta R; Picone P; Craparo EF; San Biagio PL; Giammona G; Di Carlo M
    Bioconjug Chem; 2007; 18(2):302-8. PubMed ID: 17253655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.